AMD stock price today: CES 2026 keynote looms after year-end dip

2 January 2026

NEW YORK, January 2, 2026, 02:55 ET — Market closed

Advanced Micro Devices shares last closed down about 0.5% at $214.16 as 2025 ended with a tech-led retreat
Chip stocks broadly eased into year-end, tracking thin holiday trading and profit-taking
Investors are eyeing AMD CEO Lisa Su’s CES keynote next week and the Jan. 9 U.S. jobs report for fresh catalysts

Shares of Advanced Micro Devices, Inc. (AMD) last closed on Dec. 31 down about 0.5% at $214.16. The stock traded between $213.61 and $217.54, with about 17.6 million shares changing hands.

U.S. stock markets were closed on Thursday for New Year’s Day and are set to reopen later on Friday, kicking off the first full session of 2026. That restart can amplify moves in heavily traded growth names after a holiday-thinned week. New York Stock Exchange

For AMD, the timing matters because the stock is closely tied to investor views on data-center spending and artificial intelligence. AI accelerators — specialized chips used to train and run AI models — have become a key battleground where AMD competes with rivals including Nvidia, alongside its server and PC processors.

Wall Street ended 2025’s final session lower, with the S&P 500 down 0.74% and the Nasdaq down 0.76%, Reuters reported. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity is low. Reuters

Semiconductor stocks also leaned lower into year-end. The Nasdaq US Smart Semiconductor Index fell 1.47% on Dec. 31. Nasdaqomx

Some chip names fell more sharply than AMD in the same session, with Applied Materials down 1.15% and Analog Devices down 1.32%, MarketWatch data showed. MarketWatch

Before the next session, investors are also looking ahead to CES 2026, where AMD Chief Executive Lisa Su is scheduled to deliver a keynote on Jan. 5 at 9:30 p.m. ET, the company said. The show itself runs Jan. 6–9, a week that often brings product and demand messaging that can swing sentiment across chip stocks. AMD

U.S. economic data is another near-term driver for semiconductors, which tend to react to shifts in rate expectations. The Labor Department’s monthly employment report for December 2025 is scheduled for Jan. 9 at 8:30 a.m. ET. Bureau of Labor Statistics

The Federal Reserve’s next policy meeting is scheduled for Jan. 27–28, according to its calendar. Traders often reprice growth stocks quickly when the outlook for interest rates changes. Federal Reserve

Shan Ahmed Khan Latest posts

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

View all

FDA rejects Corcept and Outlook filings; shares slump
January 2, 2026, 8:11 AM EST. Two FDA complete response letters halted prospects for Corcept Therapeutics' relacorilant and Outlook Therapeutics' bevacizumab formulation. The agency rejected requests for approval on Dec. 31, citing insufficient evidence of effectiveness. For Corcept, the drug, an oral glucocorticoid receptor antagonist, failed to show superiority to placebo in one of two Phase III trials; the FDA said additional data would be needed to establish a favorable benefit-risk profile in Cushing's syndrome. Analysts, including Truist, warned new trials could be required, dimming the stock's outlook; shares fell about 50% on Dec. 31, with price targets trimmed. For Outlook, the bid for an ophthalmic bevacizumab in wet AMD was rejected for the third time; the stock slid to about $0.62 premarket Jan. 2. Outlook said it remains committed and is exploring pathways.